Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Evelo Biosciences, Inc. (EVLO)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Assets |
| Cash and equivalents | 7.6 | 27.5 | 47.9 | 69.1 | 92.0 | 39.6 | 68.4 | 95.9 |
| Other current assets | 3.6 | 2.6 | 3.6 | 3.3 | 5.0 | 3.5 | 2.6 | 2.0 |
| Total current assets | 11.3 | 30.1 | 51.6 | 72.3 | 97.0 | 43.1 | 71.0 | 97.9 |
| Property, plant, and equipment, net | 2.4 | 4.4 | 4.8 | 5.5 | 5.8 | 6.1 | 6.6 | 7.8 |
| Other fixed assets | 1.4 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.3 | 1.4 |
| Total assets | 20.8 | 42.0 | 64.4 | 86.3 | 111.9 | 58.8 | 87.9 | 116.5 |
| |
| Accounts payable | 3.8 | 1.5 | 1.8 | 1.6 | 2.2 | 1.8 | 1.6 | 2.5 |
| Accrued expenses | 5.2 | 9.5 | 7.9 | 12.5 | 10.4 | 9.9 | 13.1 | 15.6 |
| Current portion of long-term debt | 43.9 | 43.8 | 0.0 | 10.1 | 5.9 | 1.8 | 0.0 | 0.0 |
| Current portion of long-term debt | 43.9 | 43.8 | | 10.1 | 5.9 | 1.8 | | |
| Other current liabilities | 2.7 | 2.5 | 2.7 | 2.8 | 2.8 | 2.7 | 2.7 | 2.6 |
| Total current liabilities | 55.5 | 57.2 | 12.4 | 26.9 | 21.4 | 16.2 | 17.4 | 20.7 |
| Long-term debt | | | 43.6 | 36.7 | 40.7 | 44.8 | 46.6 | 46.5 |
| Other liabilities | 11.4 | 12.1 | 13.4 | 13.4 | 14.1 | 14.7 | 15.3 | 16.1 |
| Total liabilities | 66.9 | 69.4 | 69.4 | 77.0 | 76.3 | 75.6 | 79.2 | 83.4 |
| |
| Shareholders' equity [+] | -46.1 | -27.4 | -5.0 | 9.3 | 35.6 | -16.8 | 8.7 | 33.1 |
| Paid-in capital | 529.5 | 527.1 | 524.1 | 514.9 | 510.7 | 427.7 | 423.3 | 419.1 |
| Retained earnings | -575.7 | -554.6 | -529.2 | -505.7 | -475.1 | -444.6 | -414.7 | -386.0 |
| Tangible shareholders' equity | -46.1 | -27.4 | -5.0 | 9.3 | 35.6 | -16.8 | 8.7 | 33.1 |
|